Clinical dilemma of DKA and Covid-19 infection: A case report

“Coronavirus.” World Health Organization, World Health Organization, www.who.int/emergencies/diseases/novel-coronavirus-2019. Ma, 2020, Diabetes patients with Covid-19 need better blood glucose management in Wuhan, China, Sichuan Da Xue Xue Bao Yi Xue Ban, 146 Westerberg, 2013, Diabetic ketoacidosis: evaluation and treatment, Am Fam Physician, 87, 337 Westphal, 1996, The occurrence of diabetic ketoacidosis in non-insulin-dependent diabetes and newly diagnosed diabetic adults, Am J Med, 101, 19, 10.1016/S0002-9343(96)00076-9 Dalton, 2003, Plasma C-reactive protein levels in severe diabetic ketoacidosis, Ann Clin Lab Sci, 33, 435 Singhal, 2020, A review of coronavirus disease-2019 (COVID-19), Indian J Pediatr, 87, 281, 10.1007/s12098-020-03263-6 Zhang, 2020, The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105954 Grissom, 2015, Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome, Crit Care Med, 43, 288, 10.1097/CCM.0000000000000715